Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study

We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayoubkhani, Daniel, Bosworth, Matthew L, King, Sasha, Pouwels, Koen B, Glickman, Myer, Nafilyan, Vahé, Zaccardi, Francesco, Khunti, Kamlesh, Alwan, Nisreen A, Walker, A Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494414/
https://www.ncbi.nlm.nih.gov/pubmed/36168555
http://dx.doi.org/10.1093/ofid/ofac464
_version_ 1784793792330596352
author Ayoubkhani, Daniel
Bosworth, Matthew L
King, Sasha
Pouwels, Koen B
Glickman, Myer
Nafilyan, Vahé
Zaccardi, Francesco
Khunti, Kamlesh
Alwan, Nisreen A
Walker, A Sarah
author_facet Ayoubkhani, Daniel
Bosworth, Matthew L
King, Sasha
Pouwels, Koen B
Glickman, Myer
Nafilyan, Vahé
Zaccardi, Francesco
Khunti, Kamlesh
Alwan, Nisreen A
Walker, A Sarah
author_sort Ayoubkhani, Daniel
collection PubMed
description We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds ratio, 0.59 [95% confidence interval, .50–.69]), emphasizing the need for public health initiatives to increase population-level vaccine uptake.
format Online
Article
Text
id pubmed-9494414
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-94944142022-09-26 Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study Ayoubkhani, Daniel Bosworth, Matthew L King, Sasha Pouwels, Koen B Glickman, Myer Nafilyan, Vahé Zaccardi, Francesco Khunti, Kamlesh Alwan, Nisreen A Walker, A Sarah Open Forum Infect Dis Brief Report We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds ratio, 0.59 [95% confidence interval, .50–.69]), emphasizing the need for public health initiatives to increase population-level vaccine uptake. Oxford University Press 2022-09-12 /pmc/articles/PMC9494414/ /pubmed/36168555 http://dx.doi.org/10.1093/ofid/ofac464 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Ayoubkhani, Daniel
Bosworth, Matthew L
King, Sasha
Pouwels, Koen B
Glickman, Myer
Nafilyan, Vahé
Zaccardi, Francesco
Khunti, Kamlesh
Alwan, Nisreen A
Walker, A Sarah
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
title Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
title_full Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
title_fullStr Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
title_full_unstemmed Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
title_short Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
title_sort risk of long covid in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494414/
https://www.ncbi.nlm.nih.gov/pubmed/36168555
http://dx.doi.org/10.1093/ofid/ofac464
work_keys_str_mv AT ayoubkhanidaniel riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT bosworthmatthewl riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT kingsasha riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT pouwelskoenb riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT glickmanmyer riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT nafilyanvahe riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT zaccardifrancesco riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT khuntikamlesh riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT alwannisreena riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy
AT walkerasarah riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy

Ejemplares similares